| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Oncology and Pharmacology, Wayne State University School of Medicine, and the Michigan Cancer Foundation, Detroit, Michigan 48201 [D. K.], and the Laboratories, Medical Research Council of Ireland, Trinity College, Dublin [J. G. B.]
A series of benzo-2,1,3-oxadiazoles (benzofurazans) and their N-oxides (benzofuroxans) inhibit incorporation of precursors into nucleic acids and protein by murine leukemia cells. At slightly higher levels, substantial single- and double-strand DNA breakage was observed. At still higher concentrations, inhibition of phosphorylation of uridine and thymidine was found. Structure-activity relationships show that only compounds bearing appropriate substitutions at positions 4 and 7 were effective inhibitors of biosynthetic pathways. Such compounds appear to interact with a wide variety of biological systems and may be useful in elucidating modes of macromolecule synthesis.
1 Supported in part by Grants CA-16053 and CA-07177 from the National Cancer Institute, NIH, and by the Irish Cancer Society.
2 To whom requests for reprints should be addressed, at Darling Memorial Center, 4160 John R Street, Detroit, Mich. 48201.
Received 3/20/75. Accepted 9/ 9/75.
This article has been cited by other articles:
![]() |
M. Honma, M. Stubbs, I. Collins, P. Workman, W. Aherne, and F. M. Watt Identification of Novel Keratinocyte Differentiation Modulating Compounds by High-Throughput Screening J Biomol Screen, December 1, 2006; 11(8): 977 - 984. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |